文献速递肝病消化道肿瘤与早癌

医疗保险原发性肝癌患者的临终关怀:对资源利用和死亡率的影响

Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.
PubMed 文献 · Aliment Pharmacol Ther · 2018-01-03

该横断面研究利用2002至2009年SEER数据库纳入3385例原发性肝癌患者,分析临终关怀的决定因素及其对资源利用和生存的影响。未入临终关怀者更年轻、非白人且病情更重,两组一年死亡率相似(P=.413),但未入组者住院费用更高(中位31607美元 vs 22316美元,P<.0001)。临终关怀入组时间越短与死亡率降低相关(HR每日0.99,95%CI 0.98-0.99)。

要点

  • 未入临终关怀者更年轻、非白人且病情更重(P<.05)。
  • 两组一年死亡率相似(P=.413)。
  • 未入临终关怀者住院费用中位31607美元 vs 入组者22316美元(P<.0001)。

核心结论

  • 原发性肝癌患者入临终关怀可带来生存和资源利用方面的获益。
  • 某些临床和人口学因素可能构成临终关怀入组的障碍。
  • 需要进一步研究以充分理解原发性肝癌患者中的这些障碍。

研究设计与样本

  • 横断面研究,利用2002至2009年监测、流行病学和最终结果注册库(SEER)数据库,共纳入3385例原发性肝癌患者。
  • 使用logistic回归分析临终关怀相关变量,使用Cox比例风险模型评估一年死亡风险。

主要发现

  • 与入临终关怀者相比,未入组者更年轻、非白人且病情更重(P<.05)。
  • 半数原发性肝癌患者在诊断后六个月内死亡,两组一年死亡率相似(P=.413)。
  • 调整基线特征后,临终关怀入组时间越短与死亡率降低相关(HR每日0.99,95%CI 0.98-0.99)。
  • 年龄较大、失代偿性肝硬化和晚期肿瘤分期与临终关怀入组时间缩短相关(均P<.05)。
  • 亚裔/太平洋岛民种族和放射外科治疗史与临终关怀入组时间延长相关(均P<.05)。

局限性

  • 需要进一步研究以充分理解原发性肝癌患者中临终关怀入组的障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have assessed the impact of hospice care in patients with primary liver cancer. AIM: To examine the determinants of hospice care and its effects on resource utilisation and survival among Medicare beneficiaries with primary liver cancer. METHODS: We utilised the Surveillance, Epidemiology and End result Registry (SEER) database from 2002 to 2009 for this cross-sectional study. A total of 3385 patients with primary liver cancer were included. We used logistic regression to discern variables associated with hospice and Cox proportional hazards models to evaluate one-year mortality risk. RESULTS: Compared to patients who enrolled in a hospice, those patients who did not, were younger, non-White and sicker (P < .05 for all). Half of all patients with primary liver cancer died within six months of diagnosis, and one-year mortality was similar in both groups (P = .413). After adjusting for baseline characteristics [age at diagnosis, race, disease severity, tumour stage and treatment], shorter time to hospice care was associated with reduced mortality (HR per day: 0.99 [95% CI, 0.98-0.99]). Older age, decompensated cirrhosis and advanced tumours stage were associated with decreased time to hospice, while Asian/Pacific Islander race and history of radiosurgery were associated with increased time to hospice (all P < .05). Hospitalisations were more costly for those who never enrolled in a hospice compared to hospice enrollees (median $31 607 [$18 394-$54 254] vs $22 316 [$13 741-$36 170], P < .0001). CONCLUSIONS: Hospice enrolment of patients with primary liver cancer provides survival and resource utilisation benefits. Some clinical and demographic factors may represent barriers to hospice enrolment. Further studies are needed to fully understand these barriers in patients with primary liver cancer.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Fukui N, Golabi P, Otgonsuren M, et al. Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality. Aliment Pharmacol Ther. 2018. PMID: 29314093. doi:10.1111/apt.14484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。